Aratana Therapeutics Inc (NASDAQ:PETX)

4.12
Delayed Data
As of 4:15pm ET
 -0.06 / -1.44%
Today’s Change
3.91
Today|||52-Week Range
7.67
-21.67%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 6.00. The median estimate represents a +142.72% increase from the last price of 4.12.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.21
Sales
$6.2M
Reporting Date
Mar 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually -6.62%
 
 
 
 
 
 

Sales

Growthquarterly 1.05%
 
 
 
 
 
 
Growthannually -44.58%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.